Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RIME-IVF study
2024-518057-41-00Phase 4Authorised
- Sponsor
- Rigshospitalet
- Start
- Oct 2024
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bisoprolol, metoprolol, atenolol, nadolol, propranolol and 2 more in ventricular fibrillation (VF) and unexplained cardiac arrest (UCA), sponsored by Rigshospitalet. Planned start Oct 2024; status: authorised.
02
Drugs
bisoprololmetoprololatenololnadololpropranolol
03
Conditions
ventricular fibrillation (VF)unexplained cardiac arrest (UCA)
Beyond the preview
Go deeper on 2024-518057-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-518057-41-00.